Cargando…

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study

BACKGROUND: The extent of SARS-CoV-2 exposure and transmission in Mali and the surrounding region is not well understood, although infection has been confirmed in nearly 14,000 symptomatic individuals and their contacts since the first case in March 2020. We aimed to estimate the cumulative incidenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagara, Issaka, Woodford, John, Kone, Mamady, Assadou, Mahamadoun Hamady, Katile, Abdoulaye, Attaher, Oumar, Zeguime, Amatigue, Doucoure, M’Bouye, Higbee, Emily, Lane, Jacquelyn, Doritchamou, Justin, Zaidi, Irfan, Esposito, Dominic, Kwan, Jennifer, Sadtler, Kaitlyn, Dicko, Alassane, Duffy, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095226/ https://www.ncbi.nlm.nih.gov/pubmed/33948607 http://dx.doi.org/10.1101/2021.04.26.21256016

Ejemplares similares

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study
por: Sagara, Issaka, et al.
Publicado: (2021)

SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali
por: Sagara, Issaka, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali
por: Woodford, John, et al.
Publicado: (2021)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
por: Woodford, John, et al.
Publicado: (2022)

“Spatial heterogeneity of environmental risk in randomized prevention trials: consequences and modeling”
por: Guindo, Abdoulaye, et al.
Publicado: (2019)

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
por: Gaoussou, Santara, et al.
Publicado: (2022)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
por: Dama, Souleymane, et al.
Publicado: (2018)

Adapting malaria clinical trials infrastructure to implement COVID-19 epidemiology studies: Response to a public health emergency amid safe continuation of a research enterprise
por: Woodford, John, et al.
Publicado: (2022)

Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali
por: Dicko, Alassane, et al.
Publicado: (2008)

Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren
por: Maiga, Hamma, et al.
Publicado: (2020)

Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
por: Diarra, Modibo, et al.
Publicado: (2021)

Phytochemical Composition and Antioxidant Capacity of Three Malian Medicinal Plant Parts
por: Muanda, François, et al.
Publicado: (2011)

Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults
por: Diallo, Hama, et al.
Publicado: (2019)

Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
por: Thera, Mahamadou A, et al.
Publicado: (2006)

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy
por: Kone, Aminatou, et al.
Publicado: (2020)

Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali
por: Kone, Abdoulaye K, et al.
Publicado: (2010)

Phase 1 Study of a Combination AMA1 Blood Stage Malaria Vaccine in Malian Children
por: Dicko, Alassane, et al.
Publicado: (2008)

Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children
por: Djimde, Abdoulaye A., et al.
Publicado: (2016)

Non-Apical Membrane Antigen 1 (AMA1) IgGs from Malian Children Interfere with Functional Activity of AMA1 IgGs as Judged by Growth Inhibition Assay
por: Miura, Kazutoyo, et al.
Publicado: (2011)

Spatio-Temporal Variability of Malaria Incidence in the Health District of Kati, Mali, 2015–2019
por: Katile, Abdoulaye, et al.
Publicado: (2022)

Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial
por: Sagara, Issaka, et al.
Publicado: (2009)

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

Evaluation of the protective efficacy of a spatial repellent to reduce malaria incidence in children in Mali compared to placebo: study protocol for a cluster-randomized double-blinded control trial (the AEGIS program)
por: Van Hulle, Suzanne, et al.
Publicado: (2022)

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali
por: Dicko, Alassane, et al.
Publicado: (2010)

Blastocystis Colonization Is Associated with Increased Diversity and Altered Gut Bacterial Communities in Healthy Malian Children
por: Kodio, Aly, et al.
Publicado: (2019)

An unusual case of Dyke–Davidoff–Masson syndrome revealed by status epilepticus in a Malian patient
por: Djimdé, Samba O., et al.
Publicado: (2022)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

A novel mutation in the GARS gene in a Malian family with Charcot‐Marie‐Tooth disease
por: Yalcouyé, Abdoulaye, et al.
Publicado: (2019)

Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential
por: Gonçalves, Bronner P., et al.
Publicado: (2017)

Descriptive study of cases of schizophrenia in the Malian population
por: Coulibaly, Souleymane dit Papa, et al.
Publicado: (2021)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

Establishing Reference Ranges of Hematological Parameters from Malian Healthy Adults
por: Kone, B, et al.
Publicado: (2017)

Haematological and Biochemical Reference Values for Healthy Population of Maferinyah Rural Community in Guinea
por: Béavogui, Abdoul Habib, et al.
Publicado: (2020)

Candidate Polymorphisms and Severe Malaria in a Malian Population
por: Toure, Ousmane, et al.
Publicado: (2012)

Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali
por: Maiga, Hamma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lg9h7tlqroc0alaimj9i4n7ogc